Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency.
Aso M, Yamamoto TT, Kuroda M, Wada J, Kubota Y, Ishikawa K, Maezawa Y, Teramoto N, Tawada A, Asada S, Aoyagi Y, Kirinashizawa M, Onitake A, Matsuura Y, Yasunaga K, Konno SI, Nishino K, Yamamoto M, Miyoshi J, Kobayashi N, Tanio M, Ikeuchi T, Igari H, Mitsukawa N, Hanaoka H, Yokote K, Saito Y. Aso M, et al. Among authors: hanaoka h. Heliyon. 2022 Nov 1;8(11):e11271. doi: 10.1016/j.heliyon.2022.e11271. eCollection 2022 Nov. Heliyon. 2022. PMID: 36387451 Free PMC article.
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS collaborators. Furuta S, et al. Among authors: hanaoka h. Ann Rheum Dis. 2024 Jan 2;83(1):96-102. doi: 10.1136/ard-2023-224343. Ann Rheum Dis. 2024. PMID: 37734880 Clinical Trial.
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients.
Aoki A, Iwamura C, Kiuchi M, Tsuji K, Sasaki A, Hishiya T, Hirasawa R, Kokubo K, Kuriyama S, Onodera A, Shimada T, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Nakamura S, Urushibara T, Kaneda S, Sakao S, Nishida O, Takahashi K, Kimura MY, Motohashi S, Igari H, Ikehara Y, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Kikuchi T, Nakayama T, Yokote K, Hirahara K. Aoki A, et al. Among authors: hanaoka h. J Clin Immunol. 2024 Apr 22;44(4):104. doi: 10.1007/s10875-024-01708-7. J Clin Immunol. 2024. PMID: 38647550 Free PMC article.
Antibody Responses and Infection Prevention following the Sixth Vaccination using the BA.1 bivalent COVID-19 vaccine among Healthcare workers during the XBB variant Dominance in Japan.
Yahaba M, Asano H, Saito K, Murata S, Kawasaki K, Chiba H, Yokota S, Yoshikawa H, Herai Y, Yamagishi K, Shiko Y, Matsushita K, Hanaoka H, Taniguchi T, Yokote K, Nakajima H, Ido E, Igari H. Yahaba M, et al. Among authors: hanaoka h. Jpn J Infect Dis. 2024 Nov 29. doi: 10.7883/yoken.JJID.2024.116. Online ahead of print. Jpn J Infect Dis. 2024. PMID: 39617483 Free article.
Exploratory clinical trial to evaluate the efficacy and safety of transdermal electrical stimulation in patients with central retinal artery occlusion.
Miura G, Fujiwara T, Iwase T, Ozawa Y, Shiko Y, Kawasaki Y, Nizawa T, Tatsumi T, Baba T, Kurimoto T, Mori S, Nakamura M, Hanaoka H, Yamamoto S. Miura G, et al. Among authors: hanaoka h. PLoS One. 2023 Feb 24;18(2):e0282003. doi: 10.1371/journal.pone.0282003. eCollection 2023. PLoS One. 2023. PMID: 36827287 Free PMC article. Clinical Trial.
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
Okonogi N, Murata K, Yamada S, Habu Y, Hori M, Kurokawa T, Inaba Y, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Koto M, Hasegawa S, Ishikawa H, Hanaoka H, Shozu M, Tsuji H, Usui H. Okonogi N, et al. Among authors: hanaoka h. Int J Mol Sci. 2023 Jun 23;24(13):10565. doi: 10.3390/ijms241310565. Int J Mol Sci. 2023. PMID: 37445743 Free PMC article. Clinical Trial.
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.
Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Ozawa Y, Shiko Y, Inaba Y, Kurokawa T, Hanaoka H, Iwanami S, Kim K, Iwami S, Watashi K, Miyazawa K, Umeyama T, Yamagoe S, Miyazaki Y, Wakita T, Sumiyoshi M, Hirayama T, Izumikawa K, Yanagihara K, Mukae H, Kawasuji H, Yamamoto Y, Tarumoto N, Ishii H, Ohno H, Yatera K, Kakeya H, Kichikawa Y, Kato Y, Matsumoto T, Saito M, Yotsuyanagi H, Kohno S. Miyazaki T, et al. Among authors: hanaoka h. Microbiol Spectr. 2023 Jun 15;11(3):e0431122. doi: 10.1128/spectrum.04311-22. Epub 2023 May 4. Microbiol Spectr. 2023. PMID: 37140398 Free PMC article. Clinical Trial.
353 results